BioCentury

7:00 AM GMT, Jul 16, 2001
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Emerging Company Profile

Milagen: Antibodies, quick time

Antibodies have been used as biochemical reagents for more than 50 years, but most of the attention for both reagent and therapeutic use has been on monoclonals. Milagen Inc. is using its expertise in rapidly producing polyclonal antibodies to create tools to identify targets for drug discovery and to find disease biomarkers. The company's goal is to create an antibody to every protein

Read the full 631 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.